Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.79 USD
+0.03 (3.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.78 -0.01 (-0.78%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BNGO 0.79 +0.03(3.57%)
Will BNGO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BNGO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNGO
Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?
After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO)
BNGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Viridian Therapeutics, Inc. (VRDN) to Report a Decline in Earnings: What to Look Out for
Will Bionano Genomics, Inc. (BNGO) Report Negative Q3 Earnings? What You Should Know
QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
Other News for BNGO
3 Contrarian Investments to Make Now for Massive Upside Potential
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
Bionano Genomics announces publication on OGM's structural variation detection
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
Bionano Genomics enters partnership with Diagens